Medical marijuana Certification and its problems have made marijuana as one of the most mainstream social and medical forms of treatment in the United States.
This presentation was given on April 7, 2014 as part of FMCC 2014. Andrew Bazemore, MD, MPH serves as the Director of the Robert Graham Center for Policy and p[provided an update on studies in family medicine and primary care.
Medical marijuana Certification and its problems have made marijuana as one of the most mainstream social and medical forms of treatment in the United States.
This presentation was given on April 7, 2014 as part of FMCC 2014. Andrew Bazemore, MD, MPH serves as the Director of the Robert Graham Center for Policy and p[provided an update on studies in family medicine and primary care.
Leading Quality & Safety in Healthcare - 10.5 Critical Roles for a CEOJohn Byrnes, MD
This presentation outlines the 10.5 critical roles for healthcare CEOs in creating high-performing healthcare organizations - hospitals, medical groups, and integrated systems.
We don’t have a functional competitive market in health care in the U.S. Consequently, many of the attributes of competitive markets that are beneficial in our lives are not present in health care. One significant negative externality of a dysfunctional market is an inability to discern quality. Consumerism is critical. Includes data and analysis from the 5TH ANNUAL HEALTHGRADES PATIENT SAFETY IN AMERICAN HOSPITALS STUDY – APRIL 2008
Medicine: A State of Crisis, A State of ChangeLouis Cady, MD
This is the third of three lectures given by Dr. Cady in San Diego at the 2015 IMMH Conference. In this presentation, Dr. Cady reviews the stresses on medical care in contemporary society - including pressures on both patients and providers. The impact of poorly conceived government insurance/interference in medical care on our patients (as their co-pays and deductibles skyrocket). A move toward a new paradigm for physicians and other providers is reviewed.
APIC "Futures Summit" Presentation April 2006Noel Eldridge
This was a presentation that I was invited to give at a "Summit" - Special Board meeting with invited guests - of the Association for Professionals in Infection Control. I remeember Rick Shannon also speaking and being impressed by his work, and CDC being there too. I was invited to talk about incentives for improving patient safety in VA, and I also added in slides about my frustration with the data on HAIs at that time.
Health Care: Understanding the Future, a Canadian Perspective by Carolyn Benn...neelumaggarwal
In April of 2010, the Canada US Business Council (formerly the Canadian Club of Chicago), hosted Dr. Carolyn Bennett, Liberal Critic for Health, Parliament of Canada. This talk gave the Canadian perspective on health care in addition to showing the similarities and differences between the two health care systems.
Dr. Leonard Saltz, MD; Chief, Gastrointestinal Oncology Service; Head, Memorial Sloan Kettering
Dr. Saltz will discuss selected successes and failures in cancer research efforts, and what we can learn from each, and will take a frank look at costs of care, and at business and government policies that are undermining progress and creating disparities in access to affordable, effective care.
Clinica Esperanza/Hope Clinic "International Healthcare on the local bus line...Annie De Groot
This slideset describes programs that have been implemented at Clinica Esperanza Hope Clinic since 2009, when we moved to our permanent clinical home at 60 Valley Street in Olneyville. The slides describe our mission, our Vida Sana (healthy lifestyle) invervention, our CHEER walk in clinic, and show how the investment of time and effort by volunteers and staff members results in better health for all.
Please contact us at info@aplacetobehealthy.org if you are interested in having additional information, or at http://www.aplacetobehealthy.org
Re-use of this data and/or slides is by permission only.
HANDOUT - Hospice & Palliative Care Missouri Health Net Aug 2009Christian Sinclair
2 page handout for a presentation to Missouri HealthNet (State Medicaid Program) about hospice and palliative care issues. This handout accompanies the slideset also posted to my account.
Presentation given by Eric C. Schneider, MD, Senior Vice President for Policy and Research of The Commonwealth Fund at the University of Michigan Institute for Healthcare Policy and Innovation in Ann Arbor, MI on December 7, 2017.
Clearly identifies the root cause of skyrocketing health cost and what companies and employees can do to reduce cost of health care.
You will learn proven strategies used successfully to reduce company health cost for over 20 years.
Leading Quality & Safety in Healthcare - 10.5 Critical Roles for a CEOJohn Byrnes, MD
This presentation outlines the 10.5 critical roles for healthcare CEOs in creating high-performing healthcare organizations - hospitals, medical groups, and integrated systems.
We don’t have a functional competitive market in health care in the U.S. Consequently, many of the attributes of competitive markets that are beneficial in our lives are not present in health care. One significant negative externality of a dysfunctional market is an inability to discern quality. Consumerism is critical. Includes data and analysis from the 5TH ANNUAL HEALTHGRADES PATIENT SAFETY IN AMERICAN HOSPITALS STUDY – APRIL 2008
Medicine: A State of Crisis, A State of ChangeLouis Cady, MD
This is the third of three lectures given by Dr. Cady in San Diego at the 2015 IMMH Conference. In this presentation, Dr. Cady reviews the stresses on medical care in contemporary society - including pressures on both patients and providers. The impact of poorly conceived government insurance/interference in medical care on our patients (as their co-pays and deductibles skyrocket). A move toward a new paradigm for physicians and other providers is reviewed.
APIC "Futures Summit" Presentation April 2006Noel Eldridge
This was a presentation that I was invited to give at a "Summit" - Special Board meeting with invited guests - of the Association for Professionals in Infection Control. I remeember Rick Shannon also speaking and being impressed by his work, and CDC being there too. I was invited to talk about incentives for improving patient safety in VA, and I also added in slides about my frustration with the data on HAIs at that time.
Health Care: Understanding the Future, a Canadian Perspective by Carolyn Benn...neelumaggarwal
In April of 2010, the Canada US Business Council (formerly the Canadian Club of Chicago), hosted Dr. Carolyn Bennett, Liberal Critic for Health, Parliament of Canada. This talk gave the Canadian perspective on health care in addition to showing the similarities and differences between the two health care systems.
Dr. Leonard Saltz, MD; Chief, Gastrointestinal Oncology Service; Head, Memorial Sloan Kettering
Dr. Saltz will discuss selected successes and failures in cancer research efforts, and what we can learn from each, and will take a frank look at costs of care, and at business and government policies that are undermining progress and creating disparities in access to affordable, effective care.
Clinica Esperanza/Hope Clinic "International Healthcare on the local bus line...Annie De Groot
This slideset describes programs that have been implemented at Clinica Esperanza Hope Clinic since 2009, when we moved to our permanent clinical home at 60 Valley Street in Olneyville. The slides describe our mission, our Vida Sana (healthy lifestyle) invervention, our CHEER walk in clinic, and show how the investment of time and effort by volunteers and staff members results in better health for all.
Please contact us at info@aplacetobehealthy.org if you are interested in having additional information, or at http://www.aplacetobehealthy.org
Re-use of this data and/or slides is by permission only.
HANDOUT - Hospice & Palliative Care Missouri Health Net Aug 2009Christian Sinclair
2 page handout for a presentation to Missouri HealthNet (State Medicaid Program) about hospice and palliative care issues. This handout accompanies the slideset also posted to my account.
Presentation given by Eric C. Schneider, MD, Senior Vice President for Policy and Research of The Commonwealth Fund at the University of Michigan Institute for Healthcare Policy and Innovation in Ann Arbor, MI on December 7, 2017.
Clearly identifies the root cause of skyrocketing health cost and what companies and employees can do to reduce cost of health care.
You will learn proven strategies used successfully to reduce company health cost for over 20 years.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
How To Remove Millions in Unnecessary Healthcare Costs with Quality & Safety Tools
1. Strategies for …
Removing Millions in
Unnecessary Costs
John Byrnes, MD!
!
Clinical Associate Professor
MSU, College of Human Medicine !
!
Founder & Sr. Partner!
Byrnes Healthcare Group
5. “Our obligation, to our patients, is one of the
most sacred trusts given to us….”
By our community, our friends, our families, and our patients
6. Findings supported by Classen and Leape. PAE: Preventable Adverse Events
440,000 Deaths per Year “PAEs account for “roughly
one-sixth of all deaths that
occur in the U.S. each year.”
Sources:))James,)J,)“New,)Evidence6Based)Estimate)
of)Patient)Harms)Associated)with)Hospital)Care,”)
Journal(of(Patient(Safety,)September)2013.H
H
7. “Medical Errors May Be the Country’s Third
Leading Cause of Death”
–The Advisory Board Company, Sept. 24, 2013
9. C-Suite Leaders:
You Hold the
Key
“The culture of a company, is the
behavior of its leaders … You change the
culture of a company by changing the
behavior of its leaders.”!
!
Dick Brown
10. Safety Culture
Ignites Hospital
Turnaround
No harm events in over 835 days!
!
Top 100 Hospital last three years in a row!
!
Before – mired in controversy and almost
closed by the community
15. Disclaimer, AKA The Fine Print
All calculations performed by the Director of Decision Support, assorted financial analysts, and
verified by a Chief Financial Officer.!
!
No calculations performed by this doctor person.
17. IMPACT at One Hospital
Revenue!
$32 Million
Savings!
$36 Million
Total = $68 Million
Hospital Margin
$74 Million
Study on select conditions through November, 2008; Pediatrics, ICUs, Trauma not included.
18. $32 Million Revenue Impact
❖ ABC Health P4P Plan $ 4,274,211!
❖ XYZ P4P Plan 19,663,131!
❖ CMS Market Basket Update* 8,107,477!
❖ TOTAL $ 32,044,819
*Now VBP + >50% upside
19. Eliminating
Complications
Saved $36 M
Study on select conditions through November, 2008; Pediatrics, ICUs, Trauma not included.
20. Average Costs of Common Complications
❖ Decubitus Ulcer! ! ! ! $28,272!
❖ Post-op Deep Wound Infection! $27,814!
❖ Clostridium Difficile Colitis!! $25,401!
❖ Sepsis! ! ! ! ! $23,451!
❖ Reopen Surgical Site! ! ! $19,442!
❖ Venous Thrombosis! ! ! $15,976!
❖ Pulmonary Embolism! ! ! $16,331!
❖ UTI!! ! ! ! ! $ 9,637
Richard Fuller, Elizabeth McCullough, Mona Bao, Richard Averill, Estimating the Costs of
Potentially Preventable Hospital Acquired Complications, Health Care Finance Review,
Summer, 2009, 30:17-‐‑32
21. DVT $180,000
ARF $820,000
Abcess $75,000
Int. Obstruction $545,000
Acc. Op. Laceration $203,000
Resp. Failure $971,000
Wound Infection $260,000
TOTAL $3,054,000
Physician Leaders Save Money
A Quarter Time
Physician Leader
!
• Episode of Care: Colon Surgery!
!
• 7 Preventable Complications
A small group of physician leaders can remove $ Millions in unnecessary costs
22. Hospital Acquired Infection Rates
Adult Critical Care - 2008 to 2009
MRSA, Acinetobacter, Pseud/Sten/
Serratia, and C. diff Infections
20
15
10
5
0
Jan 08 - Dec 08 Jan 09 - Dec 09
Infection Rate per 1000 Pt. Days
42% Decrease
126 Fewer Patients
126 x $14,000 = $1.8 M
23. Hospital Acquired Infection Rates - 2008 to 2009
A Children’s Hospital
HDVCH HA MRSA, VRE, ESBL/
Amp C, C. diff, and RSV
2
1.5
1
0.5
0
Jan 08 - Dec 08 Jan 09 - Dec 09
Infection Rate per 1000 Pt. Days
46% Decrease
40 Fewer Patients
Combined Results!
166 x $14,000 = $2.3 M
24. Preventing Readmissions - Total Cost of Care
Hysterectomy! ! ! ! 6.7% to 3.8%! ! ! ! $ 42,000!
Hysterectomy CA! ! ! 4.5% to 10.6%! ! ! ! $ 153,000!
Lumbar fusion ! ! 5.4% to 4.2%! ! ! ! $ 830,000!
Peds Chemo ! ! ! 9.9% to 8.3%! ! ! ! $ 685,000!
AMI ! ! ! 12.7% to 8.3%! ! ! ! $2,085,000!
PCI ! ! ! 8.2% to 5.3%! ! ! ! $ 618,000!
EP Ablation !! ! 4.1% to 3.3%! ! ! ! $ 56,000! !
Cholecystectomy ! ! 6.9% to 3.9%! ! ! ! $ 50,000!
TOTAL!! ! ! ! ! ! ! ! ! ! ! ! $4,519,000
Clinical QI Can Remove $MILLIONS in Unnecessary Costs
25. Prevent
Readmissions
Majority of Readmissions:!
1. Didn’t fill prescriptions!
2. Didn’t get timely follow-up!
3. Care coordination
26. Opportunity Analysis - 10 Years Later
Clinical QI Can Remove $MILLIONS in Unnecessary Costs
$45,000,000 Remaining Opportunity
27. “Quality and Safety (and their related process
improvements) is the next frontier of cost
management.”
–Joseph J. Fifer, FHFMA, CPA
President & CEO, HFMA
28. Opportunity Analysis
How Much Potential
Savings (Waste)?
❖ Small Multi-Hospital System!
❖ Observed to Expected Complication Rate!
❖ >2,000 Complications!
❖ >$60,000,000
Clinical QI Can Remove $MILLIONS in Unnecessary Costs
29. 3 High-Impact Tools
SAFETY - High-Reliability
Save Lives
Save $!
Make $
Clinical QI
Performance
Improvement
30. $68,000,000
$60,000,000
$45,000,000
$4,500,000
$66,800,000
$3,054,000
$2,300,000
$6,700,000
Summary of Savings:
$ Millions
One hospital: cost + additional revenue!
Small hospital system - complications!
Opportunity after 10 years - one hospital!
Readmissions prevented!
Malpractice claim impact of HRO program!
Colon Surgery - 7 Complications!
Hospital Acquired Infections - one hospital!
Cath Lab!
TOTAL $256,354,000
31. Everyday, Remember Why You’re There …
They Entrust Us With Their Lives, Let’s Not Let Them Down !